28 April 2010
Vitamin E succinate (VES) inhibits cell growth and induces apoptosis by mitochondrial-derived ROS in SGC-7901 cells
Li JiaABCDEF, Xiao-Li HuangBD, Yan ZhaoG, Xu-Guang ZhangDG, Kun WuADFGMed Sci Monit 2010; 16(5): BR131-139 :: ID: 878535
Abstract
Background
Many reports investigated the effects of vitamin E succinate (VES) on cell growth inhibition and apoptosis in SGC-7901 cells, but the mechanisms are still unclear. This study assessed the effects of VES-induced oxidative stress on apoptosis in SGC-7901 cells and further explored its mechanism.
Material and Method
Cell growth and survival were detected by the MTT assay. Apoptosis was examined by DAPI fluorescence and an Annexin V-FITC apoptosis detection kit. The fluorescent probe CMXRos was used to analyze mitochondrial transmembrane potential by confocal microscopy. Accumulation of intracellular ROS was detected with DCFH-DA. DNA damage was evaluated by the comet assay in SGC-7901 cells. The total GSH concentration was detected by a total glutathione quantification kit. The expression level of Bcl-2 in response to VES treatment was determined by Western blot analysis.
Results
The results showed that VES induced growth inhibition and apoptosis in SGC-7901 cells as assessed by the MTT assay and apoptosis detection method. VES also induced a concentration-dependent generation of reactive oxygen species (ROS) and a concentration-dependent depletion of glutathione (GSH) in the cells. Mannitol, an inhibitor of mitochondrial oxidative damage, prevented ROS generation, GSH depletion, and apoptosis in response to VES in SGC-7901 cells.
Conclusions
VES abrogated the generation of intracellular ROS and the induction of apoptosis. The results indicate that VES induced apoptosis in SGC-7901 cells and this involved mitochondria, likely through mitochondrial- derived ROS.
Keywords: Reactive Oxygen Species - metabolism, Mitochondria - metabolism, Membrane Potentials, Microscopy, Confocal, Glutathione - metabolism, Cell Line, Cell Division - drug effects, Antioxidants - pharmacology, Vitamin E - pharmacology
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952